Abstract

This study describes utilization of large silver nanoparticles (above one hundred nanometer in diameter) synthesized by plus laser ablation method in liquid (PLAL) in growth inhibition and apoptosis induction of cancer cells. Two different types of cancer cell lines and two different types of transformed cell lines were used. These cell lines were Rabdomyosarcoma (RD), glioblastoma (AMGM), rat embryo fibroblast transformed cell line (REF) and green monkey kidney transformed cell line (VERO). Cells were challenged with diluted concentration of silver nanoparticles they were 62.5µg/ml, 30.25µg/ml, and 15.12µg/ml. The synthesized silver nanoparticles was characterized it had surface plasmon resonance peak at 411nm and particle size distribution average diameter of 193.19 nm. Growth inhibition assay revealed that these relatively large nanoparticles are lethal toward cells under investigation; this lethality was concentration dependant during 24 hours of incubation at 37°C. According to acridine orange/propidium iodide mixed fluorescent staining assay, the used concentrations were able to induce apoptosis in all cells tested. However, the highest concentration was able to induce highest apoptosis percentage in the treated cells. This was confirmed by DNA fragmentation assay as well. In conclusion this study determined that above-one hundred nanometer size silver nanoparticle is capable of inducing apoptosis in cancer cell lines.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.